japan

China Pavilion at Osaka Expo 2025 wins the Gold Award! Unilumin provides a comprehensive multimedia solution

OSAKA, Japan, Oct. 30, 2025 /PRNewswire/ -- On the evening of October 12, 2025, the Osaka Expo 2025 witnessed a…

6 days ago

PTS to Launch Japan-Origin Bitcoin Mining Investment Product via Republic Platform Under U.S. Regulation

YOKOHAMA, Japan, Oct. 28, 2025 /PRNewswire/ -- Pivotal Trend Service (PTS), a Yokohama-based infrastructure firm with deep roots in Japan's…

1 week ago

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia

TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences, Inc. (NYSE:RCUS, “Arcus”) announced that Taiho exercised its…

2 weeks ago

CASIO expands footprint in Maharashtra with the launch of its exclusive store in Colaba, Mumbai

MUMBAI, India, Oct. 13, 2025 /PRNewswire/ -- Casio Computer Co. Ltd, headquartered in Japan and the parent company of Casio India,…

3 weeks ago

Idorsia successfully completes an upsized offering of shares funding the company to overall profitability

Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,…

4 weeks ago

Hibiki Path Advisors has Requested the Board of Directors of Tomoe Corporation (1921) for a Complete Overhaul of the Medium-Term Management Plan and Establishment of a Special Committee

TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors (“Hibiki” or “We”) is a Singapore-based investment management firm that manages capital for clients in Japan…

1 month ago

Orano: Beginning of a New Phase for the Nurlikum Mining Joint Venture in Uzbekistan

PARIS--(BUSINESS WIRE)--Regulatory News: In September 2025, the state-owned enterprise Navoiyuran (Uzbekistan), the Orano group (France), and the ITOCHU Corporation (Japan)…

1 month ago

Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases

Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional…

1 month ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

1 month ago

Xinhua Silk Road: “Wuliangye Day” glistens at Expo 2025 Osaka

BEIJING, Sept. 24, 2025 /PRNewswire/ -- When the "Wuliangye Day" event opened in Osaka, western Japan recently, Chinese baijiu maker…

1 month ago